Proto Labs (PRLB) Tops Q2 EPS by 3c, provides guidance

Proto Labs (NYSE: PRLB) reported Q2 EPS of $0.38, $0.03 better than the analyst estimate of $0.35. Revenue for the quarter came in at $125.6 million versus the consensus estimate of $126.25 million.

GUIDANCE:

Proto Labs sees Q3 2024 EPS of $0.10-$0.18, versus the consensus of $0.41. Proto Labs sees Q3 2024 revenue of $117-125 million, versus the consensus of $129.6 million.

For earnings history and earnings-related data on Proto Labs (PRLB) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Eli Lilly plans European weight-loss pill launch by early 2027
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth